BDBM552590 N-[2-({4-[3-(3-chloro-2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl}oxy)ethyl]prop-2-enamide::WO2022101184, Example 3

SMILES C=CC(=O)NCCOc1cnccc1-c1[nH]c2c(c1Nc1cccc(Cl)c1C)C(=O)NCC2

InChI Key InChIKey=OSQYDTVYGLNMHO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 552590   

TargetEpidermal growth factor receptor [669-770,'SVD',771-1210](Human)
Bayer Aktiengesellschaft

WIPO
LigandChemical structure of BindingDB Monomer ID 552590BDBM552590(WO2022101184, Example 3 | N-[2-({4-[3-(3-chloro-2-...)
Affinity DataIC50: 0.270nMAssay Description: Inhibitory activity of compounds of the present invention against an Epidermal Growth Factor Receptor (EGFR) with an insertion of the amino acids se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022101184